Abstract
Introduction
Peptic ulcers with adherent clots are associated with a high-risk of rebleeding and mortality. However, the optimal management of bleeding ulcers with adherent clots remains unclear. We conducted this systematic review and meta-analysis to compare endoscopic therapy and conservative therapy to manage bleeding ulcers with adherent clots.
Methods
We systematically searched PubMed, Embase, and Web of Science databases through October 2022 to include all studies comparing the endoscopic and conservative therapeutic approaches for bleeding ulcers with adherent clots. Our primary outcome was rebleeding (overall and 30-day). The secondary outcomes were mortality (overall and 30-day), need for surgery, and length of hospital stay (LOS). The random-effects model was used to calculate the pooled odds ratios (OR) and mean differences (MD) with the corresponding confidence intervals (CI) for proportional and continuous variables, respectively.
Results
Eleven studies (9 RCTs) with 833 patients (431 received endoscopic therapy vs. 402 received conservative therapy) were included. Overall, endoscopic therapy was associated with lower overall rebleeding (OR 0.41, 95% CI 0.22–0.79, P = 0.007), 30-day rebleeding (OR 0.43, 95% CI 0.21–0.89, P = 0.002), overall mortality (OR 0.47, 95% CI 0.23–0.95, P = 0.04), 30-day mortality (OR 0.43, 95% CI 0.21–0.89, P = 0.002), need for surgery (OR 0.44, 95% CI 0.21–0.95, P = 0.04), and LOS (MD − 3.17 days, 95% CI − 4.14, − 2.19, P < 0.00001). However, subgroup analysis of randomized controlled trials (RCTs) showed no significant difference in overall mortality (OR 0.78, 95% CI 0.24–2.52, P = 0.68) between the two strategies, with numerically lower but statistically non-significant rates of overall rebleeding (7.2% vs. 18.5%, respectively; OR 0.42, 95% CI 0.17–1.05, P = 0.06), statistically lower rate of need for surgery (OR 0.28, 95% CI 0.08–0.96, P = 0.04) with endoscopic therapy compared to conservative therapy.
Conclusions
Our meta-analysis demonstrates that endoscopic therapy was overall associated with lower rates of rebleeding (overall and 30-day), mortality (overall and 30-day), need for surgery, and LOS, compared to conservative therapy for the management of bleeding ulcers with adherent clots. However, subgroup analysis of RCTs showed that endoscopic therapy was associated with numerically lower but statistically non-significant rates of overall rebleeding and a statistically lower rate of need for surgery compared to conservative therapy with similar overall mortality rates. Combined treatment with thermal therapy and injection therapy was the most effective treatment modality in reducing rebleeding risk. Further large-scale RCTs are needed to validate our findings.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10620-023-08078-x/MediaObjects/10620_2023_8078_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10620-023-08078-x/MediaObjects/10620_2023_8078_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10620-023-08078-x/MediaObjects/10620_2023_8078_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10620-023-08078-x/MediaObjects/10620_2023_8078_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10620-023-08078-x/MediaObjects/10620_2023_8078_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10620-023-08078-x/MediaObjects/10620_2023_8078_Fig6_HTML.png)
Similar content being viewed by others
References
Haddad FG et al. In-hospital acute upper gastrointestinal bleeding: what is the scope of the problem? World J Gastrointest Endosc 2019;11:561–572.
Chak A et al. Effectiveness of endoscopy in patients admitted to the intensive care unit with upper GI hemorrhage. Gastrointest Endosc 2001;53:6–13.
Laine L, McQuaid KR. Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials. Clin Gastroenterol Hepatol 2009;7:33–47.
Laine L. Management of ulcers with adherent clots. Gastroenterology 2002;123:632–636.
Kahi CJ et al. Endoscopic therapy versus medical therapy for bleeding peptic ulcer with adherent clot: a meta-analysis. Gastroenterology 2005;129:855–862.
Laine L et al. ACG clinical guideline: upper gastrointestinal and ulcer bleeding. Off J Am Coll Gastroenterol 2021;116:899–917.
Wu HZ et al. Efficacy of endoscopic therapy vs drug therapy in peptic ulcer bleeding with an adherent blood clot. World Chin J Digestol 2016;24:796–800.
Telwani AA, Baba AH, Mujoo MY, Ashraf Y, Rasheed K. Endoscopic vs medical therapy for bleeding peptic ulcers with adherent clot: a randomized comparative trial. J Hepatol Gastroint Dis 2017;3:150.
Kim SH et al. Comparison between endoscopic therapy and medical therapy in peptic ulcer patients with adherent clot: a multicenter prospective observational cohort study. Korean J Gastroenterol 2015;66:98–105.
Page MJ et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71.
Luo D et al. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res 2018;27:1785–1805.
Borenstein M et al. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 2010;1:97–111.
Higgins JP et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557–560.
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603–605.
Moher D et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998;352:609–613.
Matthewson K et al. Randomized comparison of Nd YAG laser, heater probe, and no endoscopic therapy for bleeding peptic ulcers. Gastroenterology 1990;98:1239–1244.
Jung HK et al. Comparison of oral omeprazole and endoscopic ethanol injection therapy for prevention of recurrent bleeding from peptic ulcers with nonbleeding visible vessels or fresh adherent clots. Am J Gastroenterol 2002;97:1736–1740.
Bleau BL et al. Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy. Gastrointest Endosc 2002;56:1–6.
Jensen DM et al. Randomized trial of medical or endoscopic therapy to prevent recurrent ulcer hemorrhage in patients with adherent clots. Gastroenterology 2002;123:407–413.
Kim J II et al. Oral proton pump inhibitors are as effective as endoscopic treatment for bleeding peptic ulcer: a prospective, randomized, controlled trial. Dig Dis Sci 2007;52(12):3371–3376. https://doi.org/10.1007/s10620-007-9814-4.
Sung JJ et al. The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots: a randomized comparison. Ann Intern Med 2003;139:237–243.
Bini EJ, Cohen J. Endoscopic treatment compared with medical therapy for the prevention of recurrent ulcer hemorrhage in patients with adherent clots. Gastrointest Endosc 2003;58:707–714.
O’Brien JD, Day SJ, Burnham WR. Controlled trial of small bipolar probe in bleeding peptic ulcers. Lancet 1986;1:464–467.
Kim JS et al. Guidelines for nonvariceal upper gastrointestinal bleeding. Gut Liver 2020;14:560–570.
Author information
Authors and Affiliations
Contributions
AB, YA-A, AMM and SG: study design; data revision, manuscript drafting and revision. AB and MM: statistical analysis. WS, MFHM, KE, RM, EM-S and FJ: data acquisition and interpretation; manuscript drafting. MA-H, KA and UB: study supervision; critical revision for intellectual content.
Corresponding author
Ethics declarations
Conflict of interest
The authors declared no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
An editorial commenting on this article is available at https://doi.org/10.1007/s10620-023-08082-1.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Beran, A., Al-Abboodi, Y., Majzoub, A.M. et al. Endoscopic Versus Conservative Therapy for Bleeding Peptic Ulcer with Adherent Clot: A Comprehensive Systematic Review and Meta-Analysis. Dig Dis Sci 68, 3921–3934 (2023). https://doi.org/10.1007/s10620-023-08078-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-023-08078-x